The use of short-acting (2-adrenergic agonists (SABAs) monotherapy provide quick relief of acute asthma symptoms (65.7%). Combinations of β2-adrenergic agonist and corticosteroid to treat acute asthma (27, 5%) and 6.8% of patients treated asthma by combining three drugs.